secwatch.observer — SEC 8-K summary
======================================

Issuer:     PROCEPT BioRobotics Corp (PRCT)
CIK:        0001588978
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001588978-26-000002
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PROCEPT BioRobotics Q4 rev $76.4M (+12% YoY), net loss $29.8M; FY26 guidance $390-410M
--------------------------------------------------------------------------------

- Q4 total revenue $76.4M (+12% YoY); U.S. procedures ~12,200 (+69% YoY).
- Q4 net loss $29.8M vs $18.9M loss; adjusted EBITDA loss $19.0M vs $10.3M.
- U.S. install base 718 systems (+42% YoY); handpiece ASP $3,340 (+5% sequentially).
- FY 2026 revenue guidance $390-410M (27-33% growth); U.S. procedure growth 39-48%.
- FY 2026 gross margin ~65%; operating expenses ~$350M; adj. EBITDA loss $30-17M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/0001588978-26-000002-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1588978/000158897826000002/prct-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001588978-26-000002

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer